Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rofaida, El Naggar"'
Autor:
Shahira A Ramadan, Dalia M Abdel Halim, Rofaida El-Naggar, Nahed M Ibrahim, Marwa S El-Mesidy
Publikováno v:
Journal of the Egyptian Women’s Dermatologic Society, Vol 17, Iss 3, Pp 146-151 (2020)
Background Acne vulgaris (AV) is a chronic inflammatory disease with multifactorial etiology and a significant psychological disability. Inflammation is a fundamental process in the early and late stage of acne. Physical symptoms of AV include sorene
Externí odkaz:
https://doaj.org/article/5dd9179009e44f19a62081cd4e75def0
Publikováno v:
Journal of the Egyptian Women’s Dermatologic Society, Vol 17, Iss 3, Pp 146-151 (2020)
Background Acne vulgaris (AV) is a chronic inflammatory disease with multifactorial etiology and a significant psychological disability. Inflammation is a fundamental process in the early and late stage of acne. Physical symptoms of AV include sorene
Publikováno v:
The American Journal of dermatopathology. 44(1)
Autor:
Mohamed H.M. EL-Komy, Rofaida El Naggar, Heba A. Abdelkader, Eman El-Nabarawy, Dina Elantably
Publikováno v:
Journal of Thrombosis and Thrombolysis. 49:687-689
Enoxaparin is one of the most commonly used anticoagulants in the management of thromboembolic events. Herein we report a unique case of enoxaparin induced eruptive angiokeratomas in a patient with a history of ischemic cardiomyopathy who presented w
Publikováno v:
The American Journal of Dermatopathology. 44:77-77
Autor:
Samia M, Esmat, Rehab A, Hegazy, Heba I, Gawdat, Rania M, Abdel Hay, Riham S, Allam, Rofaida, El Naggar, Hoda, Moneib
Publikováno v:
Lasers in surgery and medicine. 49(9)
Female pattern hair loss (FPHL) is the most common form of hair loss in women. Nevertheless, its management represents a real challenge. Among the FDA approved therapeutic modalities for FPHL are topical minoxidil and more recently low-level light th